Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.
- Published In:
- Expert opinion on biological therapy, 23(8), 727-735 (2023)
- Authors:
- Zhang, Qin(2), Sun, Cheng, Wu, Jinying, Wu, Juan, Zhang, Xuan, Liu, Yueyue, Dou, Changlin, Qin, Huilin, Zhang, Qian, Zhou, Renpeng, Hu, Wei
- Database ID:
- RPEP-07623
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07623APA
Zhang, Qin; Sun, Cheng; Wu, Jinying; Wu, Juan; Zhang, Xuan; Liu, Yueyue; Dou, Changlin; Qin, Huilin; Zhang, Qian; Zhou, Renpeng; Hu, Wei. (2023). Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.. Expert opinion on biological therapy, 23(8), 727-735. https://doi.org/10.1080/14712598.2023.2189009
MLA
Zhang, Qin, et al. "Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.." Expert opinion on biological therapy, 2023. https://doi.org/10.1080/14712598.2023.2189009
RethinkPeptides
RethinkPeptides Research Database. "Pharmacokinetic similarity study comparing the biosimilar ca..." RPEP-07623. Retrieved from https://rethinkpeptides.com/research/zhang-2023-pharmacokinetic-similarity-study-comparing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.